The relationship between the chemical structures of dihydropyrazine derivatives and DNA strand-breakage activity

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 4, 2007, Pages 532-536

  Yamaguchi, Tadatoshi ^a   Ito, Shigeru ^b   Kashige, Nobuhiro ^c   Nakahara, Kazuhide ^d   Harano, Kazunobu ^a  

^a SOJO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bond dissociation energy; Dihydropyrazine; DNA strand breakage; Ionization potential; Semi empirical calculation method

Indexed keywords

CUPRIC ION; DIHYDROPYRAZINE; METHYL GROUP; PHENYL GROUP; PYRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CHEMICAL BOND; CHEMICAL REACTION; CHEMICAL STRUCTURE; DISSOCIATION; DNA STRAND; ELECTRICITY; ELECTRON; ENERGY; IONIZATION;

DNA; DNA DAMAGE; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROSTATICS; PYRAZINES;

EID: 34147144479     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.532     Document Type: Article

References (21)

1. Yamaguchi T., Kashige N., Mishiro N., Miake F., Watanabe K., Biol. Pharm. Bull., 19, 1261-1265 (1996).
2. Kashige N., Yamaguchi T., Miake F., Watanabe K., Biol. Pharm. Bull., 23, 1281-1286 (2000).
3. Yamaguchi T., Matsumoto S., Watanabe K., Tetrahedron Lett., 39, 8311-8312 (1998).
4. Kashige N., Takeuchi T., Matsumoto S., Takechi S., Miake F., Yamaguchi T., Biol. Pharm. Bull., 28, 419-423 (2005).
5. Yamaguchi T., Ito S., Iwase Y., Watanabe K., Harano K., Heterocycles, 51, 2305-2309 (1999).
6. Yamaguchi T., Ito S., Iwase Y., Watanabe K., Harano K., Heterocycles, 53, 1677-1680 (2000).
7. Yamaguchi T., Eto M., Harano K., Kashige N., Watanabe K., Ito S., Teterahedron, 55, 675-686 (1999).
8. Yamaguchi T., Nomura H., Matsunaga K., Ito S., Takata J., Karube Y., Biol. Pharm. Bull., 26, 1523-1527 (2003).
9. Takechi S., Yamaguchi T., Nomura H., Minematsu T., Nakayama T., Mutat. Res., 560, 49-55 (2004).
10. Kashige N., Yamaguchi T., Mishiro N., Hanazono H., Miake F., Watanabe K., Biol. Pharm. Bull., 18, 653-658 (1995).
11. Hepworth J. D., "Organic Syntheses," Collective Vol. 5, ed. by Baumgarten H. E., Wiley, New York, 1973, pp. 27-29.
12. 13C-NMR analyses. The details will be described in a separate paper preparing it now.
13. Maruoka H., Kashige N., Miake F., Yamaguchi T., Chem. Pharm. Bull., 53, 1359-1361 (2005).
14. Mibu N., Yukawa M., Kashige N., Iwase Y., Goto Y., Miake F., Yamaguchi T., Ito S., Sumoto K., Chem. Pharm. Bull., 51, 27-31 (2003).
15. Fleming I., "Frontier Orbitals and Organic Chemical Reactions," Wiley, London, 1976, pp. 37-40.
16. August O., Falijoni-Alario A., Leite L. C. C., Noberga F., Carcinogenesis, 5, 781-784 (1984).
17. Leite L. C. C., August O., Arch. Biochem. Biophys., 270, 560-572 (1989).
18. August O., Free Radical Biology Medicine, 15, 329-336 (1993).
19. Hiramoto K., Inoue M., Maeda K., Kato T., Kikugawa K., Jpn. J. Toxicol. Environ. Health, 40, 412-421 (1994).
20. Bunke A., Zerbe O., Schmid H., Burmeister G., Merkle H. P., Gander B., J. Pharm. Sci., 89, 1335-1341 (2000).
21. Teixeira P. C., Onuki J., Medeiros M. H. G., Dornemann D., Mascio P. D., Biol. Chem., 382, 913-918 (2001).